| Primary |
| Hyperlipidaemia |
29.1% |
| Hypertension |
17.3% |
| Hypercholesterolaemia |
10.2% |
| Dyslipidaemia |
8.2% |
| Coronary Artery Disease |
5.1% |
| Blood Cholesterol Increased |
4.6% |
| Angina Pectoris |
3.1% |
| Diabetes Mellitus |
3.1% |
| Supplementation Therapy |
3.1% |
| Lipids Increased |
2.6% |
| Blood Pressure Increased |
2.0% |
| Vitamin B Complex Deficiency |
2.0% |
| Angina Unstable |
1.5% |
| Cardiovascular Event Prophylaxis |
1.5% |
| Hypersensitivity |
1.5% |
| Acute Myocardial Infarction |
1.0% |
| Anaemia |
1.0% |
| Antiplatelet Therapy |
1.0% |
| Blood Cholesterol |
1.0% |
| Cardiac Failure |
1.0% |
|
| Myalgia |
22.6% |
| Rhabdomyolysis |
11.3% |
| Hepatic Enzyme Increased |
6.5% |
| Syncope |
6.5% |
| Dysphagia |
4.8% |
| Pruritus |
4.8% |
| Rash |
4.8% |
| Renal Failure Acute |
4.8% |
| Autoimmune Hepatitis |
3.2% |
| Dizziness |
3.2% |
| Haemangioma Congenital |
3.2% |
| Haematuria |
3.2% |
| Paraesthesia |
3.2% |
| Renal Artery Occlusion |
3.2% |
| Renal Impairment |
3.2% |
| Visual Acuity Reduced |
3.2% |
| Weight Decreased |
3.2% |
| Amyotrophic Lateral Sclerosis |
1.6% |
| Arthralgia |
1.6% |
| Asthenia |
1.6% |
|
| Secondary |
| Hypertension |
16.1% |
| Hypercholesterolaemia |
14.7% |
| Product Used For Unknown Indication |
11.5% |
| Hyperlipidaemia |
10.4% |
| Drug Use For Unknown Indication |
10.1% |
| Blood Cholesterol Increased |
7.9% |
| Type 2 Diabetes Mellitus |
4.6% |
| Dyslipidaemia |
3.2% |
| Hiv Infection |
3.2% |
| Angina Pectoris |
2.2% |
| Diabetes Mellitus |
2.2% |
| Type Iia Hyperlipidaemia |
2.0% |
| Depression |
1.9% |
| Cerebrovascular Accident |
1.7% |
| Antiplatelet Therapy |
1.6% |
| Cardiovascular Disorder |
1.5% |
| Prophylaxis |
1.5% |
| Blood Cholesterol |
1.3% |
| Cardiac Disorder |
1.2% |
| Insomnia |
1.2% |
|
| Rhabdomyolysis |
19.2% |
| Vomiting |
9.2% |
| Renal Failure Acute |
7.7% |
| Myalgia |
6.2% |
| Hyperhidrosis |
5.4% |
| Weight Decreased |
5.4% |
| Weight Fluctuation |
5.4% |
| Amyotrophic Lateral Sclerosis |
4.6% |
| International Normalised Ratio Increased |
4.6% |
| Optic Neuritis |
4.6% |
| Urinary Tract Infection |
4.6% |
| Pneumonia |
3.1% |
| Pulmonary Embolism |
3.1% |
| Purulent Discharge |
3.1% |
| Drug Hypersensitivity |
2.3% |
| Hepatitis |
2.3% |
| Interstitial Lung Disease |
2.3% |
| Liver Injury |
2.3% |
| Myopathy |
2.3% |
| Peripheral Sensory Neuropathy |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.1% |
| Product Used For Unknown Indication |
20.7% |
| Hypertension |
8.4% |
| Rheumatoid Arthritis |
6.4% |
| Type 2 Diabetes Mellitus |
6.3% |
| Diabetes Mellitus |
4.2% |
| Hyperlipidaemia |
3.4% |
| Prophylaxis |
2.9% |
| Hiv Infection |
2.7% |
| Hypercholesterolaemia |
2.5% |
| Atrial Fibrillation |
2.2% |
| Osteoporosis |
2.2% |
| Depression |
2.0% |
| Pain |
1.9% |
| Angina Pectoris |
1.9% |
| Dyslipidaemia |
1.8% |
| Medical Diet |
1.7% |
| Insomnia |
1.7% |
| Anxiety |
1.6% |
| Blood Cholesterol Increased |
1.5% |
|
| Weight Decreased |
9.9% |
| Myalgia |
8.4% |
| Vomiting |
8.1% |
| Pyrexia |
7.3% |
| Myocardial Infarction |
6.6% |
| Renal Failure Acute |
6.6% |
| Syncope |
6.2% |
| Liver Disorder |
4.4% |
| Thrombocytopenia |
4.4% |
| Pneumonia |
4.0% |
| Pruritus |
4.0% |
| Drug Interaction |
3.7% |
| Injection Site Pain |
3.7% |
| Renal Failure |
3.7% |
| Tremor |
3.7% |
| Urinary Tract Infection |
3.7% |
| Cerebrovascular Accident |
2.9% |
| In-stent Coronary Artery Restenosis |
2.9% |
| Incorrect Dose Administered |
2.9% |
| Loss Of Consciousness |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
57.1% |
| Hiv Infection |
28.6% |
| Blood Cholesterol |
7.1% |
| Blood Triglycerides |
7.1% |
|
|
